DHR DANAHER CORP /DE/
Industrial Instruments For Measurement, Display, and Control · NYSE · SEC CIK 313616 · Fiscal year ends 12/31
Financial factors as of 2026-09-25 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.5%
TTM net income YoY23.6%
TTM EPS YoY25.5%
Revenue 3-yr CAGR1.3%
Net income 3-yr CAGR-9.9%
Margins
Gross margin58.6%
Operating margin20.4%
Net margin16.9%
FCF margin22.4%
EBITDA margin23.5%
Returns
ROE8.3%
ROA5.0%
ROIC (approx.)6.6%
Asset turnover0.30x
Leverage & solvency
Liabilities / assets42.5%
Debt / equity0.49x
Current ratio1.63x
Interest coverage14.49x
Cash quality & payout
Operating cash flow / net income1.58x
Accruals ratio-2.9%
Payout ratio23.5%
Capex / revenue4.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $24.57B | $23.88B |
| Cost of revenue | $10.04B | $9.67B |
| Gross profit | $14.52B | $14.21B |
| R&D expense | $1.60B | $1.58B |
| SG&A expense | $8.23B | $7.76B |
| Operating income | $4.69B | $4.86B |
| Interest expense | $265.00M | $278.00M |
| Pretax income | $4.23B | $4.65B |
| Income tax | $633.00M | $747.00M |
| Net income | $3.61B | $3.90B |
| EBITDA | $5.44B | $5.58B |
| EPS (basic) | 5.07 | 5.33 |
| EPS (diluted) | 5.05 | 5.29 |
| Weighted avg. shares (diluted) | 716.10M | 737.20M |
| Balance sheet | ||
| Cash & equivalents | $4.62B | $2.08B |
| Receivables | $3.91B | $3.54B |
| Inventory | $2.49B | $2.33B |
| Current assets | $12.76B | $9.50B |
| PP&E, net | $5.53B | $4.99B |
| Goodwill | $43.15B | $40.50B |
| Intangibles | $17.82B | $18.57B |
| Total assets | $83.46B | $77.54B |
| Current liabilities | $6.81B | $6.80B |
| Short-term debt | $2.00M | $505.00M |
| Long-term debt | $18.42B | $15.50B |
| Total debt | $18.42B | $16.00B |
| Total liabilities | $30.92B | $27.99B |
| Shareholders' equity | $52.53B | $49.54B |
| Net debt | $13.80B | $13.93B |
| Shares outstanding | 706.90M | 719.10M |
| Cash flow statement | ||
| Operating cash flow | $6.42B | $6.69B |
| Capital expenditure | $1.16B | $1.39B |
| Free cash flow | $5.26B | $5.30B |
| Investing cash flow | -$1.20B | -$1.98B |
| Financing cash flow | -$2.96B | -$8.38B |
| Depreciation & amortization | $750.00M | $721.00M |
| Stock-based compensation | $298.00M | $288.00M |
| Dividends paid | $878.00M | $768.00M |
| Share buybacks | $3.09B | $5.98B |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.